Clinical Trial Update: Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ganciclovir given by infusion and by mouth to treat cytomegalovirus infection in patients after donor bone marrow transplant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-12-02